These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 9589946

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Current approaches to treatment of secondary sulfonylamide drug resistance in Type II diabetes mellitus].
    Gendeleka GF.
    Lik Sprava; 2001; (2):88-90. PubMed ID: 11519442
    [Abstract] [Full Text] [Related]

  • 23. Acarbose treatment of sulfonylurea-treated non-insulin dependent diabetics. A double-blind cross-over comparison of an alpha-glucosidase inhibitor with metformin.
    Johansen K.
    Diabete Metab; 1984 Oct; 10(4):219-23. PubMed ID: 6391973
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus].
    Yamada K.
    Nihon Rinsho; 2003 Jul; 61(7):1219-23. PubMed ID: 12877088
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Efficacy of combination therapy of alpha-glucosidase inhibitor and insulin sensitizer in patients with type 2 diabetes].
    Kitaoka H.
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():464-9. PubMed ID: 12387035
    [No Abstract] [Full Text] [Related]

  • 28. The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study.
    Spengler M, Cagatay M.
    Clin Invest Med; 1995 Aug; 18(4):325-31. PubMed ID: 8549020
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Glucobay in the therapy of patients with non-insulin-dependent diabetes mellitus].
    Bodnar PM, Kononenko LO.
    Lik Sprava; 1998 May; (3):111-4. PubMed ID: 9695585
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose.
    Kihara Y, Ogami Y, Tabaru A, Unoki H, Otsuki M.
    J Gastroenterol; 1997 Dec; 32(6):777-82. PubMed ID: 9430016
    [Abstract] [Full Text] [Related]

  • 36. Acarbose-induced acute severe hepatotoxicity.
    Carrascosa M, Pascual F, Aresti S.
    Lancet; 1997 Mar 08; 349(9053):698-9. PubMed ID: 9078205
    [No Abstract] [Full Text] [Related]

  • 37. [alpha-Glucosidase inhibitor, its structure and mechanism of antidiabetic action].
    Odaka H.
    Nihon Rinsho; 2002 Sep 08; 60 Suppl 9():393-8. PubMed ID: 12387024
    [No Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of acarbose in patients with cystic fibrosis and impaired glucose tolerance.
    Kentrup H, Bongers H, Spengler M, Kusenbach G, Skopnik H.
    Eur J Pediatr; 1999 Jun 08; 158(6):455-9. PubMed ID: 10378391
    [Abstract] [Full Text] [Related]

  • 39. [Effect of acarbose in non-insulin dependent diabetes mellitus with dumping syndrome after gastrectomy].
    Hasegawa T, Makino I.
    Nihon Shokakibyo Gakkai Zasshi; 1995 Mar 08; 92(3):267. PubMed ID: 7731101
    [No Abstract] [Full Text] [Related]

  • 40. Effect of alpha-inhibitors on blood glucose and insulin levels.
    Laube H, Federlin K, Hillebrand I.
    Adv Exp Med Biol; 1988 Mar 08; 246():287-93. PubMed ID: 3074658
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.